Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Champions Oncology (CSBR) over the last 16 years, with Q4 2025 value amounting to $9.3 million.

  • Champions Oncology's Other Operating Expenses rose 88.24% to $9.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $37.4 million, marking a year-over-year increase of 105.03%. This contributed to the annual value of $36.2 million for FY2025, which is 182.38% down from last year.
  • Per Champions Oncology's latest filing, its Other Operating Expenses stood at $9.3 million for Q4 2025, which was up 88.24% from $9.9 million recorded in Q3 2025.
  • In the past 5 years, Champions Oncology's Other Operating Expenses registered a high of $10.0 million during Q2 2023, and its lowest value of $6.1 million during Q1 2021.
  • Over the past 5 years, Champions Oncology's median Other Operating Expenses value was $8.9 million (recorded in 2022), while the average stood at $8.7 million.
  • Per our database at Business Quant, Champions Oncology's Other Operating Expenses skyrocketed by 3008.99% in 2022 and then plummeted by 1267.88% in 2025.
  • Champions Oncology's Other Operating Expenses (Quarter) stood at $7.2 million in 2021, then grew by 26.13% to $9.1 million in 2022, then decreased by 7.98% to $8.4 million in 2023, then increased by 9.1% to $9.2 million in 2024, then grew by 0.88% to $9.3 million in 2025.
  • Its Other Operating Expenses was $9.3 million in Q4 2025, compared to $9.9 million in Q3 2025 and $9.9 million in Q2 2025.